breakingview  bristolmyer take 74 bln bet   market
new york reuter breakingview  bristolmyer squibb  take  74 billion bet   market   good reason  bui rival oncolog giant celgen  cost cut ’ cover  54 percent premium   target’ owner get  financi benefit bristol  hope  luck   court  multipl regulatori approv  celgen’ sharehold  skeptic 
